| Bioactivity | CDK9 inhibitor HH1 is a potent and selectively CDK9 inhibitor. CDK9 inhibitor HH1 inhibits the transcription of CDK. CDK9 inhibitor HH1 can be used in research of cancer[1]. |
| Name | CDK9 inhibitor HH1 |
| CAS | 204188-41-0 |
| Formula | C13H15N3OS |
| Molar Mass | 261.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Pandey S, et, al. Selective CDK9 Inhibition by Natural Compound Toyocamycin in Cancer Cells. Cancers (Basel). 2022 Jul 8;14(14):3340. |
CDK9 inhibitor HH1
CAS: 204188-41-0 F: C13H15N3OS W: 261.34
CDK9 inhibitor HH1 is a potent and selectively CDK9 inhibitor. CDK9 inhibitor HH1 inhibits the transcription of CDK. CDK
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.